Pricing Bills Are Popping Up Everywhere – Review of State Prescription Drug…
The price of prescription drugs has created much controversy in recent years. This article examines why the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
June 2016
Better Patient Care Doesn’t Necessarily Equal Patient Savings
In October 2012, the Centers for Medicare and Medicaid Services launched the Comprehensive Primary Care Initiative, in…
Utah “Suggestion Sheet” of Ideas to Combat Opioid Epidemic
It's no secret that state legislatures are under intense pressure to take action to battle the opioid addiction problems…
Vermont Governor Signs Drug Price Transparency Bill
On Friday, June 3, 2016, Vermont Governor Peter Shumlin signed into law a bill that aims to require greater transparency on behalf…
Shatterproof Report on Critical Elements of Effective State Opioid…
The opioid epidemic has been a prominent talking point in many circles lately, including physician groups, Congress,…
FDA Announces Information Collection Regarding Biosimilar Suffixes
The Food and Drug Administration (FDA) has announced an information collection seeking sponsors of past and present…
Massachusetts Cost Trend Report and Suggestions
Massachusetts is required to release annual Cost Trend reports that make recommendations and commitments to advance…
DOJ Announces Genentech and OSI Pharmaceuticals, LLC Settlement
The Department of Justice (DOJ) has announced that pharmaceutical companies Genentech and OSI Pharmaceuticals, LLC, will…
Jazz Pharmaceuticals Discloses DOJ Subpoena on Patient Assistance Program
Jazz Pharmaceuticals recently revealed, in a filing with the Securities and Exchange Commission, that it received a…
House Energy and Commerce Ask FDA for Update on Off Label Guidance
The House of Representatives, through the Energy and Commerce Committee, are questioning the United States Food and Drug…